Calyxt IPO – TALEN Gene Editing in Agriculture
It’s only been a week since we published our article on “GMO vs Gene Editing vs Genetic Engineering“, and we were pleasantly surprised to see that there is now a gene-editing IPO planned that is specifically focused on gene editing in agriculture. We’ve looked at various agriculture startups that keep you fed and even robots that are getting into farming, but an agtech company we haven’t discussed before called Calyxt has now filed for an IPO which means we need to dig in and see what this is all about.
About Calyxt
Founded in 2010, Calyxt isn’t your traditional startup but rather a spin-out from a company called Cellectis (NASDAQ:CLLS). We first came across Cellectis several years ago while researching our article about 7 Gene Editing Companies Investors Should Watch. Based in France, Cellectis is focused on commercializing a gene-editing technology called TALEN. We’ve written before about how CRISPR isn’t the only gene-editing technology in town as seen below:
